1
artículo
Publicado 2006
Enlace
Enlace
This paper aims to develop the thermal process integration and PINCH applying technology to the production of ethanol from sweet potato variety INIA 306 Huambachero. The first part is presented, process technology, which consisted of a first tase hydrolysis of starch. a brewing malt enzymes obtained in a maximum time of 20 minutes, followed by fermentation with yeast saccharomyces cerevisiae. providing a yield of 85 to 95 liters of ethanol per ton of sweet potato and representing about economic benefit of up to 25% reduction in production costs of ethanol per liter compared with conventional alcohol as raw sugar cane molasses.
2
artículo
Publicado 2006
Enlace
Enlace
This paper aims to develop the thermal process integration and PINCH applying technology to the production of ethanol from sweet potato variety INIA 306 Huambachero. The first part is presented, process technology, which consisted of a first tase hydrolysis of starch. a brewing malt enzymes obtained in a maximum time of 20 minutes, followed by fermentation with yeast saccharomyces cerevisiae. providing a yield of 85 to 95 liters of ethanol per ton of sweet potato and representing about economic benefit of up to 25% reduction in production costs of ethanol per liter compared with conventional alcohol as raw sugar cane molasses.
3
artículo
Introducción: El conocimiento de la Ley de Seguridad de Salud en el Trabajo debe ser un deber y un derecho de los trabajadores, para exigir su cumplimiento y poder proteger a los trabajadores de los riesgos ocupacionales. Objetivo: El objetivo fue determinar el nivel de conocimiento de salud ocupacional en trabajadores de dos hospitales de Lima. Métodos: Estudio transversal analítico, se encuestó al personal de salud laborando en el Hospital Nacional De Emergencias José Casimiro Ulloa y en el Hospital Municipal de Los Olivos. Se les consideró con buen nivel de conocimiento a aquellos cuyas respuestas correctas superaran el 50%, además de variables socio-laborales. Se obtuvieron las razones de prevalencias crudas (RPc) y ajustadas (RPa) de las variables socio-educativas según haber aprobado. Resultados: De los 207 encuestados, el 52,9% (109) tuvo un inadecuado nivel de conocimient...
4
artículo
Publicado 2019
Enlace
Enlace
Aim: To correlate levels of tumor-infiltrating lymphocytes (TIL) evaluated using the International Immuno-Oncology Biomarker Working Group methodology, and both density of tumor-infiltrating immune cell and clinicopathological features in different malignancies. Methods: 209 pathological samples from gastric cancer, cervical cancer (CC), non-small-lung cancer, cutaneous melanoma (CM) and glioblastoma were tested for TIL in hematoxylin eosin, and density of CD3+, CD4+, CD8+, CD20+, CD68+ and CD163+ cells by digital analysis. Results: TIL levels were higher in invasive margin compartments (IMC). TIL in IMC, intratumoral and stromal compartments predicted survival. CC and gastric cancer had higher TIL in intratumoral; CC and CM had higher TIL in stromal compartment and IMC. CM had the highest density of lymphocyte and macrophage populations. CD20 density was associated with survival in the ...
5
objeto de conferencia
Publicado 2023
Enlace
Enlace
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported.The combined analysis of SOFT-TEXT compared outcomes in 4,690 premenopausal women with estrogen/progesterone receptor-positive (ER/PgR+) early breast cancer randomly assigned to 5 years of exemestane + ovarian function suppression (OFS) versus tamoxifen + OFS. After a median follow-up of 9 years, exemestane + OFS significantly improved disease-free survival (DFS) and distant recurrence-free interval (DRFI), but not overall survival, compared with tamoxifen + OFS. We now rep...
